Feng Zhang

Feng Zhang
Feng Zhang
	Feng Zhang at the Forbes 30 Under 30 Summit, Boston MA. October 2, 2017
Born	October 22, 1981; Shijiazhuang, Hebei, China
Nationality	American
Alma mater	Harvard University (BA); Stanford University (PhD);
Known for	Optogenetics, CRISPR
Awards	Edward Novitski Prize (2021); Harvey Prize (2018); Keio Medical Science Prize (2018); National Academy of Sciences (2018); American Academy of Arts & Sciences (2018); Lemelson-MIT Prize (2017); Albany Medical Center Prize (2017); Gairdner Foundation International Award (2016); Tang Prize (2016); Tsuneko & Reiji Okazaki Award (2015); Alan T. Waterman Award (2014); Gabbay Award (2014); NIH Director’s Pioneer Award (2012); Perl-UNC Prize (2011);
	Scientific career
Fields	Neuroscience, Bioengineering
Institutions	MIT, Broad Institute
Academic advisors	Karl Deisseroth, George Church
Website	zlab.mit.edu

Feng Zhang (Chinese: 张锋; pinyin: Zhāng Fēng; born October 22, 1981) is a Chinese–American biochemist. Zhang currently holds the James and Patricia Poitras Professorship in Neuroscience at the McGovern Institute for Brain Research and in the departments of Brain and Cognitive Sciences and Biological Engineering at the Massachusetts Institute of Technology. He also has appointments with the Broad Institute of MIT and Harvard (where he is a core member). He is most well known for his central role in the development of optogenetics and CRISPR technologies.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.